112 related articles for article (PubMed ID: 1993329)
21. SR1 assays of alpha-fetoprotein, carcinoembryonic antigen, and prostate-specific antigen compared with corresponding established commercial assays.
Jolley NL; Bacarese-Hamilton T
Clin Chem; 1994 Jun; 40(6):895-9. PubMed ID: 7522136
[TBL] [Abstract][Full Text] [Related]
22. Quantitative tissue carcinoembryonic antigen (T CEA) assay as a screening test for severe dysplasia in colorectal adenomas.
Rosandić M; Skegro M; Paar V; Paar D; Sćukanec-Spoljar M; Juricić M; Vucelić B; Pulanić R; Rustemović N; Ostojić R; Ljubojević N
Acta Med Austriaca; 1999; 26(3):89-92. PubMed ID: 10520376
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity and specificity of Gold types 1 to 5 anti-carcinoembryonic antigen monoclonal antibodies: immunohistologic characterization in colorectal cancer and normal tissues.
Esteban JM; Paxton R; Mehta P; Battifora H; Shively JE
Hum Pathol; 1993 Mar; 24(3):322-8. PubMed ID: 7681033
[TBL] [Abstract][Full Text] [Related]
24. Determination of carcinoembryonic antigen (CEA): comparison of two different assays.
Orjasaeter H
Acta Pathol Microbiol Scand C; 1978 Dec; 86C(6):265-75. PubMed ID: 726896
[TBL] [Abstract][Full Text] [Related]
25. Can biliary carcinoembryonic antigen identify colorectal cancer patients with occult hepatic metastases?
Li Destri G; Lanteri R; Santangelo M; Torrisi B; Di Cataldo A; Puleo S
World J Surg; 2006 Aug; 30(8):1494-9. PubMed ID: 16847713
[TBL] [Abstract][Full Text] [Related]
26. Epitope mapping of the carcinoembryonic antigen by monoclonal antibodies and establishment of a new improved radioimmunoassay system.
Kuroki M; Arakawa F; Higuchi H; Matsunaga A; Okamoto N; Takakura K; Matsuoka Y
Jpn J Cancer Res; 1987 Apr; 78(4):386-96. PubMed ID: 2438262
[TBL] [Abstract][Full Text] [Related]
27. Establishment and evaluation of a new chemiluminescent enzyme immunoassay for carcinoembryonic antigen adapted to the fully automated ACCESS system.
Matsushita H; Xu J; Kuroki M; Kondo A; Inoue E; Teramura Y; Nozawa M; Senba T; Yamamoto T; Matsuoka Y
Eur J Clin Chem Clin Biochem; 1996 Oct; 34(10):829-35. PubMed ID: 8933107
[TBL] [Abstract][Full Text] [Related]
28. Immunoradiometric assay of carcinoembryonic antigen with use of avidin-biotin labeling.
Peters J; Schmidt-Gayk H; Peters B; Armbruster FP; Quentmeier A; Mathias D
Clin Chem; 1989 Apr; 35(4):573-6. PubMed ID: 2649275
[TBL] [Abstract][Full Text] [Related]
29. [Standards, options and recommendations for tumor markers in colorectal cancer].
Eche N; Pichon MF; Quillien V; Gory-Delabaere G; Riedinger JM; Basuyau JP; Daver A; Buecher B; Conroy T; Dieu L; Bidart JM; Deneux L;
Bull Cancer; 2001 Dec; 88(12):1177-206. PubMed ID: 11792611
[TBL] [Abstract][Full Text] [Related]
30. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
31. Antigenic heterogeneity of carcinoembryonic antigen in the circulation defined by monoclonal antibodies against the carbohydrate moiety of carcinoembryonic antigen and closely related antigens.
Matsunaga A; Kuroki M; Higuchi H; Arakawa F; Takakura K; Okamoto N; Matsuoka Y
Cancer Res; 1987 Jan; 47(1):56-61. PubMed ID: 2431767
[TBL] [Abstract][Full Text] [Related]
32. [Sensitivity, specificity and prognostic value of CEA in colorectal cancer: results of a Tunisian series and literature review].
Bel Hadj Hmida Y; Tahri N; Sellami A; Yangui N; Jlidi R; Beyrouti MI; Krichen MS; Masmoudi H
Tunis Med; 2001; 79(8-9):434-40. PubMed ID: 11774785
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
34. Discrepancies between thyrotropin (TSH) measurement by four sensitive immunometric assays.
Rasmussen AK; Hilsted L; Perrild H; Christiansen E; Siersbaek-Nielsen K; Feldt-Rasmussen U
Clin Chim Acta; 1997 Mar; 259(1-2):117-28. PubMed ID: 9086299
[TBL] [Abstract][Full Text] [Related]
35. Biliary carcinoembryonic antigen levels can predict metachronous liver metastasis of colorectal cancer.
Ishida H; Yoshinaga K; Gonda T; Ando M; Hojo I; Fukunari H; Iwama T; Mishima Y
Anticancer Res; 2000; 20(1B):523-6. PubMed ID: 10769718
[TBL] [Abstract][Full Text] [Related]
36. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
Knychalski B; Lukieńczuk T
Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
[TBL] [Abstract][Full Text] [Related]
37. Human anti-murine antibody interference in measurement of carcinoembryonic antigen assessed with a double-antibody enzyme immunoassay.
Price T; Beatty BG; Beatty JD; McNally AJ
Clin Chem; 1991 Jan; 37(1):51-7. PubMed ID: 1988209
[TBL] [Abstract][Full Text] [Related]
38. Detection of carcinoembryonic antigen in colonic effluent by specific anti-CEA monoclonal antibodies.
Tobi M; O'Kieffe D; Trujillo N; Nochomovitz LE; Steinberg WM
Cancer Lett; 1992 Oct; 67(1):47-54. PubMed ID: 1423244
[TBL] [Abstract][Full Text] [Related]
39. [Enzyme immunoassay of CEA using monoclonal antibody].
Arai K; Kanikawa S; Isomura M; Takemori Y; Kanda Y; Ishii M
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2161-7. PubMed ID: 6764098
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibody CIBCHTB1 defining an epitope on carcinoembryonic antigen (CEA).
Meenakshi A; Kumar NS; Vijayshanker SG
Hum Antibodies; 2000; 9(4):223-9. PubMed ID: 11341176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
